Generation of a conditional allele of the mouse prostaglandin EP4 receptor

Genesis : the Journal of Genetics and Development
André SchneiderMatthew D Breyer

Abstract

Genetic disruption of the mouse EP4 receptor results in perinatal lethality associated with persistent patent ductus areteriosus (PDA). To circumvent this, an EP4 allele amenable to conditional deletion using the Cre/loxP system was generated. The targeting construct was comprised of a floxed exon2 in tandem with the neomycin-resistance gene in intron 2, flanked by third 3' LoxP site. Mice homozygous for the targeted allele (EP4(lox+neo/lox+neo)), or following its Cre-mediated deletion (EP4(del/del)), also die within hours of birth with PDA. In contrast, mice homozygous for a partially recombined allele, retaining exon2 but lacking neo (EP4(flox/flox)), are viable and show no overt phenotype. Postnatal deletion of the floxed EP4 gene is efficiently achieved in the liver and kidney in a transgenic mouse expressing the inducible Mx1Cre recombinase. The EP4(flox) mouse should provide a useful reagent with which to examine the physiologic roles of the EP4 receptor.

References

Oct 1, 1995·American Journal of Respiratory and Critical Care Medicine·M A Horisberger
Sep 8, 1995·Science·R KühnK Rajewsky
May 26, 1998·Biochemical and Biophysical Research Communications·E SegiA Ichikawa
Jun 8, 1999·The Journal of Clinical Investigation·S L TilleyB H Koller
Oct 3, 1999·Physiological Reviews·S NarumiyaF Ushikubi
Aug 31, 2000·Annual Review of Biochemistry·W L SmithR M Garavito
Jun 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·K ValmsenN Samel
Oct 5, 2001·Nature Reviews. Genetics·M Lewandoski
Nov 16, 2002·Prostaglandins & Other Lipid Mediators·Kazuhito TsuboiAtsushi Ichikawa
Jan 17, 2003·American Journal of Physiology. Renal Physiology·André SchneiderMatthew D Breyer

❮ Previous
Next ❯

Citations

Oct 18, 2011·Cancer Metastasis Reviews·Claus Schneider, Ambra Pozzi
Mar 15, 2013·Nature·Jonathan HoggattLouis M Pelus
Mar 24, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kohei TanakaShuh Narumiya
Aug 1, 2009·Journal of the American Society of Nephrology : JASN·Huifang ChengRaymond C Harris
Jul 31, 2010·Journal of the American Society of Nephrology : JASN·Erin M Stitt-CavanaghChristopher R J Kennedy
Dec 23, 2015·The Journal of Clinical Investigation·Marthe-Sandrine Eiymo Mwa MpolloPunam Malik
Jun 24, 2015·Proceedings of the National Academy of Sciences of the United States of America·Min GaoYoufei Guan
Dec 23, 2015·The Journal of Clinical Investigation·Michael FritzDavid Engblom
Apr 20, 2005·Birth Defects Research. Part C, Embryo Today : Reviews·Yasuhide Furuta, Richard R Behringer
Sep 14, 2010·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Ambra Pozzi, Roy Zent
Mar 15, 2006·Molecular Nutrition & Food Research·Michael Lazarus
Feb 8, 2005·Biochemical and Biophysical Research Communications·Christine A ClarkMichael J Zuscik
Feb 25, 2014·Experimental Neurology·Hidetoshi TaniguchiKatrin Andreasson
Dec 24, 2014·Brain, Behavior, and Immunity·Yo OishiClifford B Saper
Jan 12, 2013·Brain, Behavior, and Immunity·Johan RuudAnders Blomqvist
Dec 2, 2008·Cell Metabolism·Vladimir R BabaevMacrae F Linton
Jul 5, 2016·Brain, Behavior, and Immunity·Anna NilssonAnders Blomqvist
Jun 2, 2016·Antioxidants & Redox Signaling·Jean-Francois ThibodeauChristopher R J Kennedy
Jun 14, 2017·Proceedings of the National Academy of Sciences of the United States of America·Andrew T V HoHelen M Blau
Feb 20, 2018·Pflügers Archiv : European journal of physiology·Christian KargerArmin Kurtz
Feb 16, 2019·Journal of the American Heart Association·Marcela HerreraThomas M Coffman
Feb 10, 2006·Journal of the American Society of Nephrology : JASN·Juuso JuhilaHarry Holthofer
Mar 31, 2019·International Immunology·Kyoshiro TsugeYukihiko Sugimoto
Nov 1, 2016·The EMBO Journal·Hiroyuki MiyoshiThaddeus S Stappenbeck
May 3, 2014·Physiological Genomics·Elaine L SheltonJeff Reese
Jul 28, 2019·Biology of Reproduction·Lauren E CarterBarbara C Vanderhyden
Apr 24, 2020·Arteriosclerosis, Thrombosis, and Vascular Biology·Taro HiromiYoshihiro Ishikawa
Oct 21, 2015·The Journal of Clinical Investigation·Ming-Zhi ZhangRaymond C Harris
Oct 28, 2019·Scientific Reports·Yoshihide MatsumotoHiroshi Seno
Apr 24, 2020·Nature·Manolis RoulisRichard A Flavell
Jul 23, 2005·The Biochemical Journal·Peter Van Meer, Jacob Raber
May 21, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ju ShiKatrin Andreasson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.